129 related articles for article (PubMed ID: 12008204)
1. Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death.
Tassone P; Tagliaferri P; Galea E; Palmieri C; Bonelli P; Martelli ML; Tuccillo F; Turco MC; Venuta S
Eur J Cancer; 2002 May; 38(8):1141-7. PubMed ID: 12008204
[TBL] [Abstract][Full Text] [Related]
2. Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line.
Arnould S; Guichard S; Hennebelle I; Cassar G; Bugat R; Canal P
Biochem Pharmacol; 2002 Oct; 64(8):1215-26. PubMed ID: 12234602
[TBL] [Abstract][Full Text] [Related]
3. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
[TBL] [Abstract][Full Text] [Related]
4. SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.
Yasui H; Hideshima T; Hamasaki M; Roccaro AM; Shiraishi N; Kumar S; Tassone P; Ishitsuka K; Raje N; Tai YT; Podar K; Chauhan D; Leoni LM; Kanekal S; Elliott G; Munshi NC; Anderson KC
Blood; 2005 Jul; 106(2):706-12. PubMed ID: 15802527
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin (L-OHP): a new reality in colorectal cancer.
Bleiberg H
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611
[TBL] [Abstract][Full Text] [Related]
6. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
[TBL] [Abstract][Full Text] [Related]
7. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.
Nabhan C; Gajria D; Krett NL; Gandhi V; Ghias K; Rosen ST
Mol Cancer Ther; 2002 Nov; 1(13):1221-7. PubMed ID: 12479703
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
[TBL] [Abstract][Full Text] [Related]
9. Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.
Arnould S; Hennebelle I; Canal P; Bugat R; Guichard S
Eur J Cancer; 2003 Jan; 39(1):112-9. PubMed ID: 12504667
[TBL] [Abstract][Full Text] [Related]
10. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
Gupta D; Podar K; Tai YT; Lin B; Hideshima T; Akiyama M; LeBlanc R; Catley L; Mitsiades N; Mitsiades C; Chauhan D; Munshi NC; Anderson KC
Exp Hematol; 2002 Jul; 30(7):711-20. PubMed ID: 12135668
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.
Soulié P; Bensmaïne A; Garrino C; Chollet P; Brain E; Fereres M; Jasmin C; Musset M; Misset JL; Cvitkovic E
Eur J Cancer; 1997 Aug; 33(9):1400-6. PubMed ID: 9337681
[TBL] [Abstract][Full Text] [Related]
12. Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.
Lou YJ; Qian WB; Jin J
Leuk Lymphoma; 2007 Jul; 48(7):1400-6. PubMed ID: 17613769
[TBL] [Abstract][Full Text] [Related]
13. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
[TBL] [Abstract][Full Text] [Related]
14. Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells.
Zhang H; Song H; Yuan R; Zhang X; Yu H; Zhao Y; Jiang T
Biochem Biophys Res Commun; 2018 Feb; 497(1):108-114. PubMed ID: 29421658
[TBL] [Abstract][Full Text] [Related]
15. Fenretinide activates caspases and induces apoptosis in gliomas.
Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP
Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
17. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
Munugalavadla V; Mariathasan S; Slaga D; Du C; Berry L; Del Rosario G; Yan Y; Boe M; Sun L; Friedman LS; Chesi M; Leif Bergsagel P; Ebens A
Oncogene; 2014 Jan; 33(3):316-25. PubMed ID: 23318440
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
Neri P; Yasui H; Hideshima T; Tassone P; Raje N; Catley LP; Ishitsuka K; Blotta S; Kiziltepe T; Ocio EM; Fulciniti M; Kanekal S; Elliott GT; Munshi NC; Anderson KC
Br J Haematol; 2006 Jul; 134(1):37-44. PubMed ID: 16803565
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line.
Marchetti P; Galla DA; Russo FP; Ricevuto E; Flati V; Porzio G; Ficorella C; Cifone MG
Anticancer Res; 2004; 24(1):219-26. PubMed ID: 15015600
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 sensitizes multiple myeloma cell lines for apoptosis induced by interferon-alpha.
Minami R; Muta K; Ilseung C; Abe Y; Nishimura J; Nawata H
Exp Hematol; 2000 Mar; 28(3):244-55. PubMed ID: 10720689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
